Sophie Madison Bilik

Ms. Sophie Madison Bilik

Dermatology, University of Miami Miller School of Medicine, Miami, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2024 in JID Innovations
Verified
Journal Article
Open access
LSLindsey G. Siegfried
Lindsey G. Siegfried
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
JBJamie Burgess
Jamie Burgess
PCPaola Catanuto
Paola Catanuto
IJIvan Jozic
Ivan Jozic
MTMarjana Tomic-Canic
Marjana Tomic-Canic
Advancements in pathology have given rise to software applications intended to minimize human error and improve efficacy of image analysis. Still, the subjectivity of image quantification performed manually and the limitations of the most ubiquitous tissue stain analysis software requiring parameters tuned by the observer, reveal the need for a highly accurate, automated nuclear quantification software specific to immunohistochemistry, with improved precision and efficiency compared with the methods currently in use. We present a method for the quantification of immunohistochemical biomarkers in keratinocyte nuclei proposed to overcome these limitations, contributing sensitive shape-focused segmentation, accurate nuclear detection, and automated device-independent color assessment, without observer-dependent analysis parameters.

9 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TGTammy Gonzalez
Tammy Gonzalez
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
OBOlivia M. Burke
Olivia M. Burke
IPIrena Pastar
Irena Pastar
Gil YosipovitchGil Yosipovitch
Gil Yosipovitch
Chronic itch is a debilitating condition characterized by persistent pruritus lasting more than six weeks, significantly impairing quality of life. While the role of the immune system and neural circuits in itch is increasingly understood, the contribution of the skin microbiome, especially in non-atopic itch disorders, remains underexplored. This review synthesizes emerging evidence on how microbial dysbiosis contributes to chronic pruritus through multiple molecular pathways: disruption of skin barrier integrity, modulation of neuroimmune signaling axes, and direct activation of pruriceptors. We highlight recent studies identifying microbiome shifts in prurigo nodularis (PN) and lichen simplex chronicus (LSC), independent of atopic dermatitis (AD). We also evaluate advances in biologics and small-molecule therapeutics, exploring how targeted immune modulation may restore microbial balance and alleviate neuroinflammation. A systems biology approach integrating microbial genomics, neurobiology, and host immunity is critical to unraveling the complex interplay between host and microbes in chronic itch, particularly in understudied non-atopic conditions that disproportionately affect vulnerable populations.

18 November 2025 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
OBOlivia Burke
Olivia Burke
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
FHFiona M. Hanly‐Jorda
Fiona M. Hanly‐Jorda
RKRobert S. Kirsner
Robert S. Kirsner
PRPaulo Romanelli
Paulo Romanelli

1 November 2025 in Wound Repair and Regeneration
Verified
Journal Article
Open access
OBOlivia Burke
Olivia Burke
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
ARAna Restrepo
Ana Restrepo
JGJulio Garcia
Julio Garcia
ZFZachary J. Frischholz
Zachary J. Frischholz
SEScott A. Elman
Scott A. Elman
Pressure injuries are a major source of morbidity in critically ill patients, and early recognition is particularly difficult in patients with darker skin tones where erythema may be missed. This prospective study evaluated thermographic imaging with the Wound Scout in 32 patients (40 wound encounters) admitted to the ICU. Abnormal temperature, defined as > ±1.1°C, was significantly associated with deep tissue pressure injury (DTPI) diagnosis, with an odds ratio of 6.1 (95% CI 1.2–36.6), sensitivity of 83% and positive predictive value of 74%. Wound Scout changed the diagnosis in 25% of encounters, most often in sacral wounds where visual inspection is limited. Performance was consistent across Fitzpatrick skin types, supporting its utility in skin of colour. Longitudinal data from a small subset ( n = 10) did not show predictive value for progression. Thermography offers an objective, equitable adjunct to clinical assessment that may improve early detection of pressure injuries.

21 August 2025
Verified
Book Chapter
Closed access
PDF file
RPRachel Papavasilopoulos
Rachel Papavasilopoulos
RSRyan Scheinkman
Ryan Scheinkman
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
AVAlexia Vignau
Alexia Vignau
IGIsabella D Guanche
Isabella D Guanche
KNKeyvan Nouri
Keyvan Nouri

26 August 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
GKGarrett P. Kraft
Garrett P. Kraft
ISIsabella Sharifi
Isabella Sharifi
FHFiona M. Hanly-Jorda
Fiona M. Hanly-Jorda
SASarah Antonevich
Sarah Antonevich
TSTakashi K. Satoh
Takashi K. Satoh
Background: Autoimmune skin diseases exhibit chronicity and site-specific relapse that are not fully explained by genetic susceptibility or cytokine signaling alone. Emerging evidence suggests that epigenetic reprogramming of skin-resident immune cells contributes to disease persistence and recurrence. Methods: We conducted a structured narrative review of the human literature by searching PubMed for studies published from database inception through March 1, 2026. The literature search was performed between February 1 and March 1, 2026 and focused on epigenetic mechanisms across major autoimmune dermatoses, including DNA methylation, histone modification, chromatin accessibility, non-coding RNA regulation, and emerging single-cell and spatial epigenomic technologies. Results: Current evidence suggests stable chromatin remodeling in keratinocytes and immune cells, including tissue-resident memory T cells, that persists after clinical resolution and may facilitate rapid disease reactivation. Environmental exposures further reinforce these epigenetic programs, contributing to disease heterogeneity, chronicity, and site-specific relapse. Conclusion: Collectively, these findings are consistent with a model in which autoimmune skin diseases are maintained by maladaptive epigenetic memory. Although causal inference remains limited by the relative scarcity of cell-type–resolved human epigenomic data and the predominance of cross-sectional studies, this framework suggests that achieving durable therapeutic remission may require reprogramming pathogenic chromatin states rather than solely suppressing inflammatory pathways.